441 related articles for article (PubMed ID: 17511564)
21. Absence of alpha 7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophy.
Guo C; Willem M; Werner A; Raivich G; Emerson M; Neyses L; Mayer U
Hum Mol Genet; 2006 Mar; 15(6):989-98. PubMed ID: 16476707
[TBL] [Abstract][Full Text] [Related]
22. Cardiomyopathy in the dystrophin/utrophin-deficient mouse model of severe muscular dystrophy is characterized by dysregulation of matrix metalloproteinases.
Delfín DA; Zang KE; Schill KE; Patel NT; Janssen PM; Raman SV; Rafael-Fortney JA
Neuromuscul Disord; 2012 Nov; 22(11):1006-14. PubMed ID: 22749475
[TBL] [Abstract][Full Text] [Related]
23. Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers.
Miyazaki D; Nakamura A; Fukushima K; Yoshida K; Takeda S; Ikeda S
Hum Mol Genet; 2011 May; 20(9):1787-99. PubMed ID: 21320869
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of brain utrophin does not rescue behavioral alterations in dystrophin-deficient mice.
Perronnet C; Chagneau C; Le Blanc P; Samson-Desvignes N; Mornet D; Laroche S; De La Porte S; Vaillend C
Hum Mol Genet; 2012 May; 21(10):2263-76. PubMed ID: 22343141
[TBL] [Abstract][Full Text] [Related]
25. Dystrophin delivery in dystrophin-deficient DMDmdx skeletal muscle by isogenic muscle-derived stem cell transplantation.
Ikezawa M; Cao B; Qu Z; Peng H; Xiao X; Pruchnic R; Kimura S; Miike T; Huard J
Hum Gene Ther; 2003 Nov; 14(16):1535-46. PubMed ID: 14577915
[TBL] [Abstract][Full Text] [Related]
26. Cardiac dysfunction and pathology in the dystrophin and utrophin-deficient mouse during development of dilated cardiomyopathy.
Chun JL; O'Brien R; Berry SE
Neuromuscul Disord; 2012 Apr; 22(4):368-79. PubMed ID: 22266080
[TBL] [Abstract][Full Text] [Related]
27. The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies.
Banks GB; Chamberlain JS
Curr Top Dev Biol; 2008; 84():431-53. PubMed ID: 19186250
[TBL] [Abstract][Full Text] [Related]
28. Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy.
Gardner KL; Kearney JA; Edwards JD; Rafael-Fortney JA
Gene Ther; 2006 May; 13(9):744-51. PubMed ID: 16307000
[TBL] [Abstract][Full Text] [Related]
29. [Study on the gene knockout model mice of Duchenne muscular dystrophy].
Chen S; Zhang C; Liu X; Gao L; Zhang W; Huang W; Lu X; Wang Z
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):210-3. PubMed ID: 12947691
[TBL] [Abstract][Full Text] [Related]
30. Utrophin Compensates dystrophin Loss during Mouse Spermatogenesis.
Chen HC; Chin YF; Lundy DJ; Liang CT; Chi YH; Kuo P; Hsieh PCH
Sci Rep; 2017 Aug; 7(1):7372. PubMed ID: 28785010
[TBL] [Abstract][Full Text] [Related]
31. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy.
D'Arcy CE; Feeney SJ; McLean CA; Gehrig SM; Lynch GS; Smith JE; Cowling BS; Mitchell CA; McGrath MJ
Hum Mol Genet; 2014 Feb; 23(3):618-36. PubMed ID: 24087791
[TBL] [Abstract][Full Text] [Related]
32. Exercise increases utrophin protein expression in the mdx mouse model of Duchenne muscular dystrophy.
Gordon BS; Lowe DA; Kostek MC
Muscle Nerve; 2014 Jun; 49(6):915-8. PubMed ID: 24375286
[TBL] [Abstract][Full Text] [Related]
33. Social stress is lethal in the mdx model of Duchenne muscular dystrophy.
Razzoli M; Lindsay A; Law ML; Chamberlain CM; Southern WM; Berg M; Osborn J; Engeland WC; Metzger JM; Ervasti JM; Bartolomucci A
EBioMedicine; 2020 May; 55():102700. PubMed ID: 32192914
[TBL] [Abstract][Full Text] [Related]
34. [Utrophin, a way to cure Duchenne muscle dystrophy].
Gillis JM
Med Sci (Paris); 2004 Apr; 20(4):442-7. PubMed ID: 15124117
[TBL] [Abstract][Full Text] [Related]
35. Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy.
Morales MG; Gutierrez J; Cabello-Verrugio C; Cabrera D; Lipson KE; Goldschmeding R; Brandan E
Hum Mol Genet; 2013 Dec; 22(24):4938-51. PubMed ID: 23904456
[TBL] [Abstract][Full Text] [Related]
36. Expression of utrophin at dystrophin-deficient neuromuscular synapses of mdx mice: a study of protected and affected muscles.
Ferretti R; Neto HS; Marques MJ
Anat Rec (Hoboken); 2011 Feb; 294(2):283-6. PubMed ID: 21235003
[TBL] [Abstract][Full Text] [Related]
37. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
[TBL] [Abstract][Full Text] [Related]
38. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.
Bia BL; Cassidy PJ; Young ME; Rafael JA; Leighton B; Davies KE; Radda GK; Clarke K
J Mol Cell Cardiol; 1999 Oct; 31(10):1857-62. PubMed ID: 10525423
[TBL] [Abstract][Full Text] [Related]
39. TAT-μUtrophin mitigates the pathophysiology of dystrophin and utrophin double-knockout mice.
Call JA; Ervasti JM; Lowe DA
J Appl Physiol (1985); 2011 Jul; 111(1):200-5. PubMed ID: 21565990
[TBL] [Abstract][Full Text] [Related]
40. [Future treatment modalities in Duchenne muscular dystrophy].
Oron A; Shuper A; Shohat M
Harefuah; 1998 Apr; 134(7):557-60. PubMed ID: 10909603
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]